Hi Stezza - I would think testing in hospital would be ok in term of how well it measured type and location of stroke but it would provide no guidance on usability in the field - both ambulance and air ambulance. For that reason, in my opinion, in-field trialling would be essential.
Ann: First Responder Device Unveiled, page-40
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
-0.005(0.26%) |
Mkt cap ! $165.4M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.94 | $1.90 | $32.16K | 16.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2617 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.94 | 5790 | 2 |
View Market Depth
| Last trade - 15.51pm 15/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |